Portfolio company
Evido Health
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
Evido Health develops AI-powered software to detect chronic liver disease using blood biomarkers for general practitioners and pharmaceutical companies.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Hepta Bio
This company develops AI-powered blood tests for chronic liver disease diagnostics to assist clinicians and pharmaceutical companies with patient identification and monitoring.
Oncoustics
This company develops AI-powered software that analyses raw ultrasound signals for non-invasive liver disease diagnostics and tissue characterisation for clinics and pharmaceutical partners.
Dxcover
This company develops an artificial intelligence platform and liquid biopsy blood tests for healthcare providers to achieve earlier cancer detection.
Aged Diagnostics
The company develops non-invasive blood tests to diagnose liver disease and stage fibrosis for healthcare providers and patients.
Carenostics
This company develops an AI platform for health systems to identify chronic disease patients earlier and streamline transplant workflows using electronic health record data.
Evident
Evident develops an artificial intelligence platform to automate patient identification and recruitment for clinical trials within healthcare organisations and research teams.
LEVY Health
This company develops clinical decision support software that diagnoses endocrine disorders and fertility issues for healthcare providers, clinics and biopharma companies.
Scanvio
Scanvio develops AI-based ultrasound software to assist clinicians in the earlier and more accurate diagnosis of endometriosis for healthcare providers.
